Company Data
Terns Pharmaceuticals Inc.
Ticker
TERN
Current Price
$52.65 -0.08%
Market Cap
$6.1B
Price Target
Refer to Report
Volume
6.4M
52wk Range
$2.215 - $53.19
Overview
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.